These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
104 related items for PubMed ID: 1014494
21. [Trial therapy of leukoses, lymphogranulomas & malignant tumors with urethane, chloroethylamine & other clinical compounds]. CHILOV K, IVANOV S, KIRCHEV P. Izv Meditsinskite Inst Bulg Akad Naukite Sofia Otd Biol Meditsinski Nauki; 1957; 14():73-129. PubMed ID: 13587006 [No Abstract] [Full Text] [Related]
22. Effect of glucuronic acid conjugate of aniline mustard on human ovarian and other tumours 'in vitro'. Rao KV, Bhat AV, Bapat CV. Indian J Cancer; 1978 Sep; 15(3):21-2. PubMed ID: 575105 [No Abstract] [Full Text] [Related]
23. Phase II evaluation of phenesterin in patients with advanced ovarian cancer. Bloom RE, Polivogianis L, Davis TE, Bennett JM, Horton J. Cancer Treat Rep; 1983 Jun; 67(6):601-2. PubMed ID: 6861167 [No Abstract] [Full Text] [Related]
28. High rates of long-lasting remissions after 5-day bendamustine chemotherapy cycles in pre-treated low-grade non-Hodgkin's-lymphomas. Bremer K. J Cancer Res Clin Oncol; 2002 Nov; 128(11):603-9. PubMed ID: 12458340 [Abstract] [Full Text] [Related]
29. [Chemotherapy of malignant brain tumors by intermittent and continuous intra-arterial infusion of antitumor agents--clinical study]. Sato O. No To Shinkei; 1966 Nov; 18(11):1103-21. PubMed ID: 4292939 [No Abstract] [Full Text] [Related]
32. Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions. Perez-Soler R, Shin DM, Siddik ZH, Murphy WK, Huber M, Lee SJ, Khokhar AR, Hong WK. Clin Cancer Res; 1997 Mar; 3(3):373-9. PubMed ID: 9815694 [Abstract] [Full Text] [Related]
33. [Recommendations for clinical practice: 2003 standards, options and recommendations for the medical front-line treatment of patients with malignant epithelial ovarian tumors. Update (summary version)]. FNCLCC. Gynecol Obstet Fertil; 2004 Nov; 32(11):993-1006. PubMed ID: 15567693 [No Abstract] [Full Text] [Related]
37. High-dose megestrol acetate therapy of ovarian carcinoma: a phase II study by the Northern California Oncology Group. Sikic BI, Scudder SA, Ballon SC, Soriero OM, Christman JE, Suey L, Ehsan MN, Brandt AE, Evans TL. Semin Oncol; 1986 Dec; 13(4 Suppl 4):26-32. PubMed ID: 3099393 [Abstract] [Full Text] [Related]
38. [Role of chemotherapy in the treatment of malignant ovarian tumors]. Netschajewa ID. Zentralbl Gynakol; 1971 Nov 27; 93(48):1659-62. PubMed ID: 5004193 [No Abstract] [Full Text] [Related]
39. Peptichemio in the therapy of malignancies (phase-I-study). The evaluation committee. Gingold N, Pittermann E, Stacher A. Int J Clin Pharmacol; 1974 Oct 27; 10(3):190-202. PubMed ID: 4426721 [No Abstract] [Full Text] [Related]